News & Updates
Filter by Specialty:
Isolated systolic hypertension tied to increased LV mass index, aortic stiffness in adolescents
Adolescents with isolated systolic hypertension (ISH), including the spurious hypertension (sHTN) subtype, show more noticeable markers of cardiac end-organ damage, higher aortic stiffness, and stroke volume than those with white-coat hypertension (WCH), a study has shown.
Isolated systolic hypertension tied to increased LV mass index, aortic stiffness in adolescents
21 May 2022Male sex, obesity among risk factors for severe COVID-19 in children
A large study by the US National COVID Cohort Collaborative (N3C) has identified factors associated with the risk of severe disease among children with SARS-CoV-2 infection as well as factors tied to an increased risk of multisystem inflammatory syndrome in children (MIS-C) as compared to acute COVID-19.
Male sex, obesity among risk factors for severe COVID-19 in children
20 May 2022Antidepressant exposure in pregnancy not a risk factor for neonatal seizures, epilepsy
In pregnant women, the use of serotonergic antidepressants does not appear to put babies at risk of developing seizures or epilepsy, as reported in a study.
Antidepressant exposure in pregnancy not a risk factor for neonatal seizures, epilepsy
20 May 2022Short-course IV antibiotics should be considered for nonbacteraemic UTI in babies
In the treatment of young infants with nonbacteraemic urinary tract infection (UTI), administering intravenous (IV) antibiotics for less than 48 hours appears to work well in the absence of meningitis, with low rates of treatment failure and serious complications, according to a study.
Short-course IV antibiotics should be considered for nonbacteraemic UTI in babies
18 May 2022BNT162b2 prevents children from getting very sick but does not make them super immune
In the period of COVID-19 pandemic predominated by the milder yet highly transmissible Omicron variant, BNT162b2 vaccination of young children can shield them against severe infection. However, the antiviral armour afforded by this vaccine weakens over time, as reported in a recent study.